Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biological Specimen Banks | 5 | 2024 | 74 | 1.560 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2023 | 462 | 1.120 |
Why?
|
| Genetic Variation | 5 | 2024 | 2165 | 1.010 |
Why?
|
| Blood Proteins | 1 | 2023 | 299 | 0.810 |
Why?
|
| Biological Evolution | 2 | 2022 | 290 | 0.810 |
Why?
|
| Genome, Human | 5 | 2022 | 1885 | 0.810 |
Why?
|
| Epilepsy | 2 | 2023 | 946 | 0.780 |
Why?
|
| Selection, Genetic | 3 | 2022 | 198 | 0.750 |
Why?
|
| Genomics | 6 | 2024 | 2836 | 0.740 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2024 | 5774 | 0.700 |
Why?
|
| Genetic Association Studies | 2 | 2023 | 1099 | 0.670 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 173 | 0.650 |
Why?
|
| Neural Stem Cells | 1 | 2020 | 182 | 0.650 |
Why?
|
| Neurons | 5 | 2024 | 2451 | 0.640 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2022 | 665 | 0.640 |
Why?
|
| Transcriptome | 3 | 2024 | 1954 | 0.640 |
Why?
|
| Schizophrenia | 2 | 2021 | 315 | 0.590 |
Why?
|
| Proteomics | 2 | 2024 | 1425 | 0.560 |
Why?
|
| Mutation, Missense | 2 | 2021 | 1193 | 0.540 |
Why?
|
| Complement C4 | 1 | 2016 | 14 | 0.540 |
Why?
|
| Genetic Testing | 1 | 2024 | 1695 | 0.500 |
Why?
|
| United Kingdom | 6 | 2024 | 289 | 0.480 |
Why?
|
| Genome-Wide Association Study | 7 | 2024 | 2348 | 0.460 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 2117 | 0.400 |
Why?
|
| Exome | 3 | 2023 | 1249 | 0.370 |
Why?
|
| Machine Learning | 2 | 2024 | 366 | 0.350 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 4136 | 0.330 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 553 | 0.310 |
Why?
|
| Anticonvulsants | 2 | 2020 | 443 | 0.240 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 366 | 0.240 |
Why?
|
| Rhombencephalon | 1 | 2024 | 47 | 0.230 |
Why?
|
| Biomarkers | 3 | 2024 | 5054 | 0.230 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2024 | 623 | 0.220 |
Why?
|
| PubMed | 1 | 2023 | 32 | 0.220 |
Why?
|
| Software | 2 | 2022 | 1389 | 0.220 |
Why?
|
| Plasma | 1 | 2023 | 146 | 0.210 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2022 | 15 | 0.210 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2022 | 13 | 0.210 |
Why?
|
| Haploinsufficiency | 1 | 2023 | 301 | 0.200 |
Why?
|
| Mutation | 6 | 2023 | 15908 | 0.200 |
Why?
|
| Databases, Genetic | 2 | 2024 | 757 | 0.200 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2022 | 188 | 0.200 |
Why?
|
| Cell Lineage | 1 | 2024 | 696 | 0.190 |
Why?
|
| Epilepsy, Generalized | 1 | 2022 | 69 | 0.190 |
Why?
|
| Epirizole | 1 | 2020 | 2 | 0.190 |
Why?
|
| Trimipramine | 1 | 2020 | 2 | 0.190 |
Why?
|
| Perphenazine | 1 | 2020 | 6 | 0.190 |
Why?
|
| Trazodone | 1 | 2020 | 8 | 0.190 |
Why?
|
| Telomere | 1 | 2024 | 549 | 0.190 |
Why?
|
| Carbamazepine | 1 | 2020 | 56 | 0.180 |
Why?
|
| Homozygote | 1 | 2023 | 771 | 0.180 |
Why?
|
| Humans | 24 | 2024 | 270457 | 0.180 |
Why?
|
| Naloxone | 1 | 2020 | 108 | 0.180 |
Why?
|
| Risperidone | 1 | 2020 | 62 | 0.180 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 200 | 0.180 |
Why?
|
| Hematopoiesis | 1 | 2023 | 604 | 0.180 |
Why?
|
| Case-Control Studies | 4 | 2024 | 6204 | 0.170 |
Why?
|
| Codon | 1 | 2020 | 261 | 0.170 |
Why?
|
| Heterozygote | 1 | 2023 | 1056 | 0.170 |
Why?
|
| Disease | 1 | 2021 | 165 | 0.170 |
Why?
|
| Phenotype | 5 | 2024 | 6497 | 0.170 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 153 | 0.170 |
Why?
|
| RNA Stability | 1 | 2020 | 134 | 0.170 |
Why?
|
| Databases, Factual | 2 | 2023 | 2234 | 0.170 |
Why?
|
| Cerebellum | 1 | 2023 | 471 | 0.170 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 547 | 0.160 |
Why?
|
| Computational Biology | 3 | 2024 | 1292 | 0.160 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 223 | 0.150 |
Why?
|
| RNA Splicing | 1 | 2020 | 361 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2024 | 4648 | 0.150 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 334 | 0.150 |
Why?
|
| Drug Discovery | 1 | 2020 | 329 | 0.150 |
Why?
|
| Alleles | 1 | 2023 | 2591 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 536 | 0.140 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 1101 | 0.140 |
Why?
|
| Genotype | 2 | 2023 | 4251 | 0.140 |
Why?
|
| Amino Acid Sequence | 1 | 2022 | 4569 | 0.130 |
Why?
|
| Antipsychotic Agents | 1 | 2020 | 429 | 0.130 |
Why?
|
| Evolution, Molecular | 1 | 2020 | 867 | 0.130 |
Why?
|
| Action Potentials | 1 | 2018 | 598 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2020 | 1573 | 0.120 |
Why?
|
| Animals | 8 | 2024 | 62021 | 0.120 |
Why?
|
| Electrodes, Implanted | 1 | 2015 | 186 | 0.120 |
Why?
|
| Mice | 6 | 2024 | 35592 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1417 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 458 | 0.090 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 1950 | 0.090 |
Why?
|
| Genetics, Population | 2 | 2022 | 259 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 5142 | 0.080 |
Why?
|
| Algorithms | 3 | 2024 | 3919 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 2355 | 0.060 |
Why?
|
| Telomere Homeostasis | 1 | 2024 | 77 | 0.060 |
Why?
|
| Aged | 4 | 2024 | 73175 | 0.060 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 164 | 0.060 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2023 | 51 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2024 | 4121 | 0.050 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2022 | 44 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2024 | 240 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2022 | 83 | 0.050 |
Why?
|
| DNA Helicases | 1 | 2024 | 450 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 105 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 163 | 0.050 |
Why?
|
| DNA, Intergenic | 1 | 2021 | 22 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 165 | 0.050 |
Why?
|
| Male | 5 | 2024 | 128105 | 0.050 |
Why?
|
| Germ Cells | 1 | 2022 | 330 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2022 | 286 | 0.040 |
Why?
|
| Female | 5 | 2024 | 148644 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 268 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2022 | 488 | 0.040 |
Why?
|
| Lipids | 1 | 2023 | 653 | 0.040 |
Why?
|
| Cell Division | 1 | 2023 | 2661 | 0.040 |
Why?
|
| Microelectrodes | 1 | 2018 | 55 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 1064 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2022 | 662 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2024 | 1502 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2018 | 363 | 0.040 |
Why?
|
| Seizures | 1 | 2023 | 1032 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 1939 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2023 | 2137 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 697 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2017 | 276 | 0.030 |
Why?
|
| Cell Movement | 1 | 2024 | 2472 | 0.030 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 376 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2022 | 4947 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 2572 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2017 | 1164 | 0.030 |
Why?
|
| Proteins | 1 | 2021 | 2044 | 0.030 |
Why?
|
| Middle Aged | 3 | 2024 | 90100 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 4364 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2018 | 5690 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 2911 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 5725 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 13383 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 81754 | 0.010 |
Why?
|